Research Topics
| Gloria BachmannSummaryAffiliation: New Jersey Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
The impact of hormones on menopausal sexuality: a literature reviewGloria A Bachmann
Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA
Menopause 11:120-30. 2004..This article reviews the literature on the impact of menopausal estrogen loss on sexuality and on the effect of hormone therapy on sexual function during menopause...- Female sexuality and sexual dysfunction: are we stuck on the learning curve?Gloria Bachmann
Department of Medicine, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
J Sex Med 3:639-45. 2006..Direct questioning by physicians about sexual function is often critical to patients' reporting of sexual concerns... 
Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trialGloria Bachmann
Division of Obstetrics and Gynecology, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA
Obstet Gynecol 111:67-76. 2008..To evaluate the efficacy of two vaginal doses of estradiol (E2) compared with placebo in the treatment of atrophic vaginitis...- Bleeding patterns associated with non-oral hormonal contraceptives: a review of the literatureGloria Bachmann
Department of Ob Gyn Reproductive Science, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ 0891 7035, USA
Contraception 79:247-58. 2009..Overall, reporting vaginal bleeding by 90-day reference periods as recommended by the WHO allows straightforward comparison of bleeding patterns between studies... - Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and managementGloria A Bachmann
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
J Reprod Med 51:447-56. 2006..The consensus panel also identified key topics and issues forfurther research, including the role of inflammatory mechanisms and genetic factors and psychosexual contributors... - Microdose transdermal estrogen therapy for relief of vulvovaginal symptoms in postmenopausal womenGloria A Bachmann
Department of Ob Gyn, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08904, USA
Menopause 16:877-82. 2009..The aim of this study was to investigate the effectiveness of microdose transdermal 17beta-estradiol (E2) therapy in postmenopausal women with moderate to severe vulvovaginal symptoms... - Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginallyGloria Bachmann
University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
Menopause 16:719-27. 2009..The aim of this study was to evaluate the efficacy and safety of low-dose conjugated estrogens (CE) cream for treatment of atrophic vaginitis... - Menopausal vasomotor symptoms: a review of causes, effects and evidence-based treatment optionsGloria A Bachmann
Department of Obstetrics and Gynecology, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick 08901, USA
J Reprod Med 50:155-65. 2005..Most herbal therapies that have been evaluated in placebo-controlled trials have shown no clinically significant benefit... - Ospemifene effectively treats vulvovaginal atrophy in postmenopausal women: results from a pivotal phase 3 studyGloria A Bachmann
Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA
Menopause 17:480-6. 2010..The aim of this study was to study the efficacy and safety of ospemifene, a new selective estrogen receptor modulator, in the treatment of vulvovaginal atrophy in postmenopausal women... - Effects of bazedoxifene in nonflushing postmenopausal women: a randomized phase 2 trialGloria Bachmann
University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
Menopause 18:508-14. 2011..The current study evaluated the vasomotor effects of bazedoxifene in healthy nonflushing postmenopausal women... - External occlusive devices for management of female urinary incontinenceGloria Bachmann
Department of Obstetrics and Gynecology, UMDNJ, New Brunswick, New Jersey 08901, USA
J Womens Health (Larchmt) 11:793-800. 2002..Other management options include pelvic floor rehabilitation by means of exercise, pharmacotherapy, intravaginal and intraurethral devices, absorbent products, and external occlusive devices... - Bleeding patterns associated with oral contraceptive use: a review of the literatureGloria Bachmann
Women s Health Institute, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901 7035, USA
Contraception 76:182-9. 2007..Reporting of the bleeding/spotting data using the WHO recommendations may be useful in objectively comparing vaginal bleeding patterns among different oral contraceptive products... - Effect of zoledronic acid compared with raloxifene on bone turnover markers in postmenopausal women with low bone densityGloria Bachmann
Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ 08901, USA
Menopause 18:851-6. 2011..The aim of this study was to assess the effects of zoledronic acid and raloxifene on bone turnover markers... - Efficacy of tolterodine on overactive bladder symptoms and sexual and emotional quality of life in sexually active womenRebecca Rogers
Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, MSC10 5580 Albuquerque, NM, 87131, USA
Int Urogynecol J Pelvic Floor Dysfunct 19:1551-7. 2008..009), and HAD Anxiety (P = 0.03) scores versus placebo (n = 210; mean +/- SD age, 47 +/- 12 years). OAB symptoms improved with tolterodine ER as did the scores of sexual health and anxiety measures in sexually active women with OAB... - Continued symptom improvement in sexually active women with overactive bladder and urgency urinary incontinence treated with tolterodine ER for 6 monthsRebecca G Rogers
Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
Int Urogynecol J Pelvic Floor Dysfunct 20:381-5. 2009..TOL ER resulted in improvements in OAB symptoms and HRQL that were maintained or greater with 6 months of use. Long-term compliance with OAB pharmacotherapy may be important for optimal treatment outcomes... - Vulvovaginal complaintsAasta Mehta
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Clin Obstet Gynecol 51:549-55. 2008..Summary of various management options such as hormonal, nonhormonal, and botanical interventions... - The accuracy of women performing vaginal pH self-testingJennifer L Kulp
UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
J Womens Health (Larchmt) 17:523-6. 2008..To determine if women could measure their vaginal pH as accurately as could physicians... - Development of a screening tool for identifying women with menorrhagia for hemostatic evaluationClaire S Philipp
Division of Hematology, Department of Medicine, UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ 08903, USA
Am J Obstet Gynecol 198:163.e1-8. 2008..A study was conducted to develop a short, easy to administer screening tool useful for stratifying women with unexplained menorrhagia for hemostatic testing for underlying bleeding disorders... - Postmenopausal uterine bleeding profiles with two forms of continuous combined hormone replacement therapyJulia V Johnson
Department of Obstetrics and Gynecology, University of Vermont College of Medicine, Burlington, VT 05405, USA
Menopause 9:16-22. 2002..5 mg norethindrone acetate (Activella; E(2)/NETA group), a newly available CCHRT preparation, over a 6-month period... - Female androgen insufficiencyGloria Bachmann
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Hospital Medical School, Women s Health Institute, 125 Patterson Street, 1CAB 2104, New Brunswick, NJ 08903 2601, USA
Obstet Gynecol Clin North Am 33:589-98. 2006..Large scale, long-term, controlled trials focusing on establishment of valid and standardized diagnosis and treatment options are needed... - Satyriasis: the antiquity term for vulvodynia?Janice McElhiney
Women s Health Institute, UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ, USA
J Sex Med 3:161-3. 2006..From our review of the ancient medical literature, we believe that the condition described by Soranus as "satyriasis in females" was actually vulvodynia... - Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinenceRebecca G Rogers
Department of Obstetrics and Gynecology, University of New Mexico School of Medicine, Albuquerque, NM 87131, USA
Curr Med Res Opin 25:2159-65. 2009..To assess the effects of tolterodine extended release (ER) on patient-reported outcomes (PROs) in sexually active women with overactive bladder (OAB) and urgency urinary incontinence (UUI)... - Expanding treatment options for women with symptomatic uterine leiomyomas: timely medical breakthroughsGloria Bachmann
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901 1977, USA
Fertil Steril 85:46-7; discussion 48-50. 2006.... - Lowest effective transdermal 17beta-estradiol dose for relief of hot flushes in postmenopausal women: a randomized controlled trialGloria A Bachmann
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Obstet Gynecol 110:771-9. 2007..To investigate the efficacy of micro-dose transdermal estrogen in relieving menopausal vasomotor symptoms... - The hypoandrogenic woman: pathophysiologic overviewGloria A Bachmann
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Women s Health Institute, New Brunswick, New Jersey 08901, USA
Fertil Steril 77:S72-6. 2002..To review the pathophysiologic changes associated with androgen insufficiency in the female... - Sexual well-being, happiness, and satisfaction, in women: the case for a new conceptual paradigmRaymond C Rosen
New England Research Institutes, Watertown, Massachussetts 02472, USA
J Sex Marital Ther 34:291-7; discussion 298-307. 2008..In this commentary article, we review recent findings and propose a new conceptual model for addressing these effects in controlled studies... 
Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control studyLauren D Arnold
Department of Epidemiology, School of Public Health, University of Medicine and Dentistry of New Jersey, Piscataway, NJ, USA
Am J Obstet Gynecol 196:128.e1-6. 2007..This study assessed the prevalence of vulvodynia symptoms in a sample of US women and compared health characteristics of symptomatic and asymptomatic women...- Chronic vulvar and other gynecologic pain: prevalence and characteristics in a self-reported surveyGloria A Bachmann
Department of Obstetrics and Gynecology, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, New Brunswick, USA
J Reprod Med 51:3-9. 2006..To characterize and assess the prevalence of chronic gynecologic pain and, more specifically, chronic vulvar pain... - Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenoneGloria Bachmann
Women's Health Institute, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA
Contraception 70:191-8. 2004..The majority of women (86%) stated that they were satisfied or very satisfied with the treatment and over 70% of women would have continued with the study medication... - Premenopausal women with sexual dysfunction: the need for a bladder function historyAasta Mehta
Women s Health Institute, UMDNJ Robert Wood Johnson Medical School, New Brunswick, NJ, USA
J Sex Med 5:407-12. 2008.... - Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessmentGloria Bachmann
Robert Wood Johnson Medical School, Women's Health Institute, New Jersey, New Brunswick, USA
Fertil Steril 77:660-5. 2002..A simplified management algorithm for women with low androgen in the presence of clinical symptoms and normal estrogen status has also been proposed... - Impact of physician gender on sexual history taking in a multispecialty practiceIrina D Burd
Department of Obstetrics and Gynecology, Thomas Jefferson University, Philadelphia, PA, USA
J Sex Med 3:194-200. 2006..Sexual concerns are common among patients; however, there is evidence to suggest that these concerns are not appropriately investigated by clinicians... - Calcium compliance: the clinician's roleGloria Bachmann
Department of Medicine, Robert Wood Johnson University Hospital, Robert Wood Johnson Medical School, University of Medicine and Dentistry of New Jersey, 125 Patterson Street, New Brunswick, NJ 08901, USA
J Reprod Med 50:896-900. 2005.... - Vulvar endometriosis presenting with dyspareunia: a case reportPamela Brug
Department of Obstetrics, Gynecology and Reproductive Sciences, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
J Reprod Med 57:175-7. 2012..Although infectious and inflammatory causes are more common, vulvar endometriosis is a rare and often overlooked etiology of dyspareunia... - Sildenafil citrate for female sexual arousal disorder: a future possibility?Corina Schoen
Robert Wood Johnson University Hospital, University of Medicine and Dentistry of New Jersey, New Brunswick, NJ, USA
Nat Rev Urol 6:216-22. 2009..Sildenafil citrate may also be effective in women with FSAD secondary to multiple sclerosis, diabetes or antidepressant use; however, more trials in these patient populations are required to confirm these findings... - Vulvodynia: characteristics and associations with comorbidities and quality of lifeLauren D Arnold
Women's Health Institute, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
Obstet Gynecol 107:617-24. 2006..As well, the association of vulvodynia with other comorbid conditions, such as fibromyalgia and irritable bowel syndrome, needs to be further evaluated. LEVEL OF EVIDENCE: II-2... - Impact of preventive osteoporosis education on patient behavior: immediate and 3-month follow-upJennifer L Kulp
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA
Menopause 11:116-9. 2004..3% v 1.7%; P = 0.03), and started hormone therapy (8% v 1%; P = 0.04). CONCLUSION: The use of an educational video on osteoporosis seems to improve patient knowledge and may positively impact health-related behaviors... - Evaluation of physical fitness in an ambulatory settingJenna Heimmel
Department of Obstetrics, Gynecology and Women s Health, UMDNJ New Jersey Medical School, New Jersey, USA
Am J Obstet Gynecol 196:522.e1-4. 2007..Except for patient report of exercise activity, no objective measures of fitness are assessed during annual gynecologic office visits... - Age and the prevalence of bleeding disorders in women with menorrhagiaClaire S Philipp
Department of Medicine, UMDNJ Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA
Obstet Gynecol 105:61-6. 2005..A study was conducted to evaluate the frequency and types of hemostatic defects occurring in adolescent and perimenopausal-age women diagnosed with menorrhagia... - Evaluating the performance of pelvic floor exercises in women with urinary incontinenceAllison L Russell
Women's Health Institute, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901-1977, USA
J Reprod Med 50:529-32. 2005..Training objectively improved pelvicfloor exercises in the cohort who performed them incorrectly and improved urinary incontinence in the majority of subjects... - Assessment of vulvodynia symptoms in a sample of U.S. women: a follow-up national incidence surveyJocelyn T Sutton
UMDNJ Robert Wood Johnson Medical School, Piscataway, New Jersey 08901, USA
J Womens Health (Larchmt) 17:1285-92. 2008..To estimate the annual incidence of vulvodynia-like symptoms and evaluate triggers of vulvar pain in a sample of U.S. women... - Family planning attitudes of medically underserved LatinasClaudia P Rivera
University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick, New Jersey 08901, USA
J Womens Health (Larchmt) 16:879-82. 2007..To evaluate the cultural and socioeconomic factors that may influence family planning decisions in Latinas attending a community health center... - Improved GI tolerability with monthly ibandronate in women previously using weekly bisphosphonatesNeil Binkley
Department of Medicine, Institute on Aging, Universityof Wisconsin Madison, 2870 University Avenue, Madison, WI 53705, USA
South Med J 102:486-92. 2009.... - Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES)Paolo Raggi
Tulane University Health Sciences Center, New Orleans, LA 70112 2699, USA
Circulation 112:563-71. 2005..We used sequential electron-beam tomography (EBT) scanning to quantify changes in coronary artery calcium (CAC) as a measure of atherosclerosis burden in patients treated with statins... - Recurrent vulvar itchingGloria A Bachmann
Obstet Gynecol 106:639; author reply 639. 2005 - Interpreting studies of nutritional prevention: a perspective using calcium as a modelRobert P Heaney
Creighton University, Omaha, Nebraska 68131, USA
J Womens Health (Larchmt) 14:889-97. 2005 - Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause SocietyWulf H Utian
Menopause 15:584-602. 2008..The benefit-risk ratio for menopausal HT is favorable close to menopause but decreases with aging and with time since menopause in previously untreated women... - Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulationTeri B Pearlstein
Department of Psychiatry and Human Behavior, Brown Medical School, Providence, RI 02905, USA
Contraception 72:414-21. 2005....
Research Grants
- VULVODYNIA PREVALENCE AND EFFICACY OF 4 INTERVENTIONSGloria Bachmann; Fiscal Year: 2004..Our ultimate goal is to share findings from this and related research with the broadest cross-spectrum of women that we can. ..